Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. MEDICAL MARIJUANA STOCKS Message Board

Good Post Check this Press Release: Finalists Anno

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 4861
(Total Views: 304)
Posted On: 01/02/2021 2:30:57 PM
Avatar
Posted By: toodles
Re: MLR_Lite #1762
Good Post Check this Press Release: Finalists Announced in Competition to Combat Social Isolation.

October 15, 2020
FOR IMMEDIATE RELEASE
Contact: ACL Office of External Affairs, (202) 401-4634, ACLinfo@acl.hhs.gov




Finalist: MIMI-Rx™ Resource and Referral Solution
Team Lead: Stanley Campbell, EagleForce Health, Inc.

Partners: Maryland Living Well Center of Excellence and Partners in Care Foundation

The Medications and Immunizations Management Initiative (MIMI-Rx™) Resource and Referral Solution (RRS) is a consumer-facing, HIPAA-compliant, HITECH secure web and mobile platform for telehealth and remote patient monitoring. It connects consumers to providers of health care, social services and other resources through a single entry point and EagleForce Health can provide devices to support that connection and enable the individual to share their information with all providers. The team incorporated computer-assisted assessments and screening strategies, such as the Upstream Social Isolation Risk Screener (U-SIRS), to increase the platform’s ability to screen older adults for loneliness and social isolation risk in community and/or clinical settings. U-SIRS uses a nationally validated algorithm to assess an individual’s connectivity and interaction with others and guide the individual to local resources that best fit those needs. Additional assessment tools embedded in the platform screen for other clinical and social needs, and MIMI-Rx™ can include resources to address them in the suggestions it provides. In addition, MIMI-Rx™ offers users the option of connecting to both the assessment and directory of resources through a phone call or text message.

https://acl.gov/news-and-events/announcements...-isolation


TOODLES


(2)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us